Skip to content

19-054 - Evaluation and Safety of 2 Dose Regimens of Intravenous Study Medication for Postoperative Gastrointestinal Dysfunction in Participants Undergoing Large- and Small-Bowel Resection

Status: open

TAK-954-2004: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large– and Small–bowel Resection

Treatment for laparoscopic-assisted or open partial small- or large- bowel resection.

Contact Us


The purpose of this study is to assess the efficacy and safety of intravenous (IV) TAK-954 for accelerating the recovery of gastrointestinal (GI) function postsurgery in participants undergoing open or laparoscopic-assisted partial small- or large-bowel resection.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.